OTC drug/cosmetics national uniformity Senate floor debate set for July 28.
This article was originally published in The Tan Sheet
Executive Summary
OTC/COSMETICS NATIONAL UNIFORMITY BACKED BY TWO FORMER FDA COMMISSIONERS, Arthur Hull Hayes, MD, and Charles Edwards, MD, in July 23 and July 21 letters to Senate Labor & Human Resources Chairman James Jeffords (R-Vt.). Both letters emphasize that language in the OTC and cosmetics national uniformity clause of Jefford's FDA reform bill (S 830) already allows states to petition for exemption from a national standard. Edwards writes that "national uniformity should play a greater role in FDA-state relations." He points out, however, that "valid and growing state interests also must be recognized" and that S 830 accommodates these concerns.